Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phagolysosomal and endosomal lumen represents the internal aqueous environment of vesicles involved in the endocytic and phagocytic pathways (NCBI, 2023). This compartment is characterized by an acidic pH, maintained by V-ATPase proton pumps, which is essential for the activity of various acid hydrolases that degrade proteins, lipids, and nucleic acids (PubMed, 2021). It plays a vital role in the immune response by destroying engulfed pathogens and processing antigens for presentation (StatPearls, 2023). Many pharmacological agents, known as lysosomotropic drugs, target this space by diffusing across membranes and becoming protonated, thereby trapping them inside and increasing the luminal pH (PubChem, 2024). This mechanism is utilized in treating malaria and certain viral infections, although the lumen itself is a cellular location rather than a discrete molecular target (Wikipedia, 2024).
Drugs typically act by altering the luminal pH (alkalinization) or by accumulating within the acidic environment to inhibit specific luminal enzymes or disrupt membrane integrity (PubMed, 2022).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phagolysosomal and endosomal lumen.